New clinical data from the DeCidE1 trial: Results on DPX-Survivac, low dose cyclophosphamide (CPA), and epacadostat (INCB024360) in subjects with advanced recurrent epithelial ovarian cancer
Titel:
New clinical data from the DeCidE1 trial: Results on DPX-Survivac, low dose cyclophosphamide (CPA), and epacadostat (INCB024360) in subjects with advanced recurrent epithelial ovarian cancer
Auteur:
Dorigo, O. Oza, A.M. Tanyi, J.L. Strauss, J. Pejovic, T. Ghamande, S. Ghatage, P. Villella, J. Fiset, S. MacDonald, L.D. Torrey, H. Weir, G.M. Hrytsenko, O. Stanford, M.M. Newton, R. Leopold, L. Rosu, G.N.